Acute lymphoblastic leukemia diagnostic study of choice: Difference between revisions
Kamal Akbar (talk | contribs) |
Kamal Akbar (talk | contribs) No edit summary |
||
| Line 8: | Line 8: | ||
==Diagnostic study of choice== | ==Diagnostic study of choice== | ||
*The diagnostic study of choice for acute lymphoblastic lymphoma is bone marrow biopsy | *The diagnostic study of choice for acute lymphoblastic lymphoma is bone marrow biopsy | ||
*A bone marrow biopsy must show 20% or greater blasts of lymphoid immunophenotype | *A bone marrow biopsy must show 20% or greater blasts of lymphoid immunophenotype<ref name="pmid25408859">{{cite journal| author=Chiaretti S, Zini G, Bassan R| title=Diagnosis and subclassification of acute lymphoblastic leukemia. | journal=Mediterr J Hematol Infect Dis | year= 2014 | volume= 6 | issue= 1 | pages= e2014073 | pmid=25408859 | doi=10.4084/MJHID.2014.073 | pmc=4235437 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25408859 }} </ref> | ||
*This diagnostic criteria is very similar to that of acute myeloid leukemia.<ref name="pmid28665419">{{cite journal| author=Terwilliger T, Abdul-Hay M| title=Acute lymphoblastic leukemia: a comprehensive review and 2017 update. | journal=Blood Cancer J | year= 2017 | volume= 7 | issue= 6 | pages= e577 | pmid=28665419 | doi=10.1038/bcj.2017.53 | pmc=5520400 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28665419 }} </ref> | *This diagnostic criteria is very similar to that of acute myeloid leukemia.<ref name="pmid28665419">{{cite journal| author=Terwilliger T, Abdul-Hay M| title=Acute lymphoblastic leukemia: a comprehensive review and 2017 update. | journal=Blood Cancer J | year= 2017 | volume= 7 | issue= 6 | pages= e577 | pmid=28665419 | doi=10.1038/bcj.2017.53 | pmc=5520400 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28665419 }} </ref> | ||
Revision as of 19:20, 29 January 2019
|
Acute lymphoblastic leukemia Microchapters |
|
Differentiating Acute lymphoblastic leukemia from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Acute lymphoblastic leukemia diagnostic study of choice On the Web |
|
American Roentgen Ray Society Images of Acute lymphoblastic leukemia diagnostic study of choice |
|
FDA on Acute lymphoblastic leukemia diagnostic study of choice |
|
CDC on Acute lymphoblastic leukemia diagnostic study of choice |
|
Acute lymphoblastic leukemia diagnostic study of choice in the news |
|
Blogs on Acute lymphoblastic leukemia diagnostic study of choice |
|
Directions to Hospitals Treating Acute lymphoblastic leukemia |
|
Risk calculators and risk factors for Acute lymphoblastic leukemia diagnostic study of choice |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Shyam Patel [2]
Overview
The diagnostic study of choice for acute lymphoblastic lymphoma is bone marrow biopsy.
Diagnostic study of choice
- The diagnostic study of choice for acute lymphoblastic lymphoma is bone marrow biopsy
- A bone marrow biopsy must show 20% or greater blasts of lymphoid immunophenotype[1]
- This diagnostic criteria is very similar to that of acute myeloid leukemia.[2]
References
- ↑ Chiaretti S, Zini G, Bassan R (2014). "Diagnosis and subclassification of acute lymphoblastic leukemia". Mediterr J Hematol Infect Dis. 6 (1): e2014073. doi:10.4084/MJHID.2014.073. PMC 4235437. PMID 25408859.
- ↑ Terwilliger T, Abdul-Hay M (2017). "Acute lymphoblastic leukemia: a comprehensive review and 2017 update". Blood Cancer J. 7 (6): e577. doi:10.1038/bcj.2017.53. PMC 5520400. PMID 28665419.